Navigation Links
QuickSite LV Lead

ProductsQuickSite LV Lead
Company St. Jude Medical, Inc.
Item QuickSite LV Lead
Features 
  • S-shaped distal lead body - Enhances acute and chronic stability
  • OTW or stylet approach compatibility - Gives the option of using either approach during the procedure to ensure a successful implant
  • Back-loading or front-loading capability - Gives the implanting physician the option to use whichever approach is most appropriate
  • Composite lead body and conductors - Provides pushability and torqueability to improve handling. Soft distal portion allows tracking along a wire. Improves overall maneuverability.
  • Fast-Pass coating - Allows multiple leads to slide against one another easily. Designed to potentially reduce dislodgment of one lead while manipulating another lead.
  • Steerable tip Designed to improve maneuverability and navigation into tortuous veins
  • Grooved, circumferential tip electrode - Enhances chronic stability and thresholds
  • Steroid elution - Reduces tissue inflammation and scarring, and lowers acute and chronic thresholds
  • Titanium nitride fractal coating - Lowers polarization and increases stimulation efficiency
  • Radiopaque suture sleeve - Enables suture sleeve visibility on fluoroscopy without blocking visibility of the underlying coils
  • Traffic Light stylet configuration Offers easy identification of stylet stiffness
Description The QuickSite model 1056K LV lead is designed to ensure chronic stability and to promote shorter procedure times, delivering a complete package of quality, performance, and reliability.

The QuickSite LV lead is a highly innovative, technologically advanced left ventricular lead, including such features as S-shaped fixation, over-the-wire or stylet-driven compatibility, and front and back loading capability. The steroid-eluting lead is implantable with a 7 Fr introducer.

Info St. Jude Medical, Inc.
Customer Service: (800) 328-9634
Web site: http://www.sjm.com

Related medicine products :

1. T2™ Humeral Nailing System
2. Ascent Primary Knee System - Ascent/Maxim CoCr I-Beam Tibial Tray
3. Advance Uni-Comparental Knee Components - Uni All-poly Tibial Component
4. Advance Uni-Comparental Knee Components - Uni Metal-backed Tibial Component
5. Advance Uni-Compartmental Knee Components - Uni Metal-backed Tibial Component
6. BioPro Uni-compartmental Knee System - Uni-compartmental Tibial Tray
7. Genesis II Tibial Instrumentation
8. MIS Tibial Stylus
9. MIS Tibial Saw Guide
10. Tibial Alignment Guide Assembly
11. MIS Proximal Tibial Alignment Guide
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products:
(Date:12/2/2008)...tatives from the fitness,company Burn Machine ( w...rs,Hospitals for Children in Chicago last month t...cause; The Burn Machine donated more than $1500,w...the first ever Shriners,Wheelchair Bodybuilding C...-bin/prnh/20081203/CLW007 ) , "We knew the...
(Date:12/2/2008)...stantially higher rates of mental health problems ...from a systematic review and meta-analysis publish... studies over the past four decades containing dat...s people, Seena Fazel and colleagues of the Univer...84 homeless individuals based in the US, UK, mainl...
(Date:12/2/2008)...oups of immigrants in Oslo. Compared with Norwegia...s are seen for risk factors and actual diseases. T...stitute of Public Health. Five of the largest immi... ethnic Norwegian population. The report was commi... The five immigrant groups in this study come fro...
(Date:12/2/2008)...k, data review finds , , TUESDAY, Dec. 2... on the safety of the drug Trasylol (aprotinin), u...ry. , Trasylol is already the subject of contro...rom the market in 2007. , In the new study, Can... from 49 randomized clinical trials. They conclude...
Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2
...ake is an effective way of identifying prostate ca...steoporosis, according to a research.// Researche..., Barcelona, Spain, looked at a cross-section of 3...nt were receiving androgen-deprivation therapy (AD...
...gain directed doctors in government-run medical ho...mes.// An official letter has been issued directi...pitals, primary health centres, community health c...ibe only the generic names of medicines and not th...
...idents of suicides and fratricides in the armed fo...or steps to "urgently" address the// issue. "The ...o be a cause of concern and must be addressed urge...ng the five-day Army Commanders' Conference here. ...
???'Of all the rights of women, the greatest is to be a mother.' ????………….. Lin Yutang been eulogized, since the// time of eve, as the symbol of abysmal and unconditional love. It is that exclusiv
Other Medicine News:Health News:Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient 2Health News:Antony Concerned Over Growing Suicide Rates in Armed Forces 2Health News:Magic of Motherhood Through Egg Donation 2Health News:Magic of Motherhood Through Egg Donation 3Health News:Magic of Motherhood Through Egg Donation 4
(Date:12/2/2008)...tCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biop...y antibodies for the treatment of cancer, inflamma... it has entered into an agreement expanding its Co...sbridge Capital Limited, a private investment grou...has committed to provide up to $75 million of capi...
(Date:12/1/2008)...eGen has announced that an oral,presentation of ...clinical,trial of TG101348 in myeloproliferative ...merican Society of Hematology (ASH) Meeting. , ..., Title: A Phase I Study of TG10... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... a two-way switch that, if turned off, causes lymp... they lose their identity and become more like blo...c. 1 Scientists at St.... that a certain differentiated cell type is so rea...stant expression of a gene called Prox1 to dissu...
(Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Stern + Associates Signs New Clients to Health Care Practice 26591 1Stern + Associates Signs New Clients to Health Care Practice 26591 2Hurricane Devastation Touches the Nations Blood Supply 26589 1Hurricane Devastation Touches the Nations Blood Supply 26589 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 1alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 2alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 3
...NEVA, Switzerland, May 2, 2007 – Merck,Seron...I data on,safinamide, a new agent in Phase III dev...sease symptoms, were presented by Professor,Fabriz...th Annual,Meeting in Boston, Massachusetts, USA. T...d, double blind, placebo-controlled,international...
...ublished today in the Journal of the National Canc...and, 2 May 2007 - In a study published today in,th...novative cancer,drug MabThera was shown to improve...less of the chemotherapy regimen used.1 The,review...as seen for,the first time in patients with mantle...
Other Medicine Technology:Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4